Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID07272460

Time Restricted-eating and Metabolic Health in Patients With Type 2 Diabetes

Led by Mount Sinai Hospital, Canada · Updated on 2026-02-11

112

Participants Needed

1

Research Sites

17 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying time-restricted eating as a potential way to preserve pancreatic beta-cell function and improve blood sugar control in people with type 2 diabetes. This randomized controlled trial focuses on adults who have been diagnosed with type 2 diabetes within the last 10 years and have a body mass index (BMI) over 25. The study aims to evaluate whether limiting eating to a certain time window each day can help with metabolic health and diabetes management. Participants will be randomly assigned to one of two groups. One group will follow a time-restricted eating plan where they fast for 18 hours each day and eat only during a 6-hour window from 2 to 8 PM for 52 weeks. The other group will follow standard lifestyle recommendations based on Diabetes Canada guidelines, which encourage regular meal timing but do not specify fasting periods. Both groups will be monitored throughout the year-long study. During the study, participants will undergo assessments to measure their insulin secretion and sensitivity, insulin resistance, and the amount of time their blood sugar stays within target ranges. These measures will be compared between the two groups after 52 weeks. Participants’ weight stability, medication use, and adherence to the assigned eating plan will be tracked. Safety and metabolic health will be monitored throughout the trial, which is expected to continue until July 2029.

CONDITIONS

Brief Title

Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals with BMI 25 kg/m2 or higher and type 2 diabetes diagnosed within the past 10 years
  • Age between 18 and 75 years inclusive
  • Stable weight over the past 12 weeks with less than 5% change (self-reported)
  • Diabetes treatment limited to lifestyle changes or metformin, DPP-4 inhibitors, or SGLT2 inhibitors alone or in combination
  • Ability to read and understand English
Not Eligible

You will not qualify if you...

  • Current use of insulin, glucagon-like peptide-1 receptor agonists, or sulfonylureas for diabetes
  • Use of any other medications for weight loss
  • Previous weight-loss surgery such as gastric bypass or gastric band
  • History of any eating disorder
  • Currently pregnant or breastfeeding
  • Kidney dysfunction with estimated glomerular filtration rate below 25 ml/min
  • New York Heart Association class II-IV heart failure
  • Significant liver disease or elevated liver enzymes
  • Cancer requiring treatment within the last 5 years except basal cell skin cancer
  • Any other factor that may limit study adherence
  • Participation in another diabetes or metabolic health research study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 52 weeks

Participants follow either a time-restricted eating schedule with 18 hours of fasting and a 6-hour eating window daily or standard lifestyle recommendations for diabetes management.

Regular visits for dietary counseling and assessments

Trial Site Locations

Total: 1 location

1

Leadership Sinai Centre for Diabetes

Toronto, Ontario, Canada, M5T3L9

Actively Recruiting

Loading map...

Research Team

C

Caroline K Kramer, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

The PILI 'Aina Project to Improve Cardiometabolic Health in...

Type 2 Diabetes

Actively Recruiting

2 locations

A Clinical Study to Evaluate the Pharmacokinetic and Pharmac...

Type 2 Diabetes

Actively Recruiting

1 location

A Feasibility Study of Optimal Non-Pharmacological Lifestyle...

Type 2 Diabetes

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial